143 related articles for article (PubMed ID: 8514446)
1. trk and ret proto-oncogene expression in human neuroblastoma specimens: high frequency of trk expression in non-advanced stages.
Borrello MG; Bongarzone I; Pierotti MA; Luksch R; Gasparini M; Collini P; Pilotti S; Rizzetti MG; Mondellini P; De Bernardi B
Int J Cancer; 1993 Jun; 54(4):540-5. PubMed ID: 8514446
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
Kogner P; Barbany G; Dominici C; Castello MA; Raschellá G; Persson H
Cancer Res; 1993 May; 53(9):2044-50. PubMed ID: 8481906
[TBL] [Abstract][Full Text] [Related]
3. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
[TBL] [Abstract][Full Text] [Related]
4. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
Kogner P; Barbany G; Björk O; Castello MA; Donfrancesco A; Falkmer UG; Hedborg F; Kouvidou H; Persson H; Raschella G
Prog Clin Biol Res; 1994; 385():137-45. PubMed ID: 7972205
[TBL] [Abstract][Full Text] [Related]
5. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas.
Wajjwalku W; Nakamura S; Hasegawa Y; Miyazaki K; Satoh Y; Funahashi H; Matsuyama M; Takahashi M
Jpn J Cancer Res; 1992 Jul; 83(7):671-5. PubMed ID: 1381340
[TBL] [Abstract][Full Text] [Related]
6. Specific expression of the ret proto-oncogene in human neuroblastoma cell lines.
Ikeda I; Ishizaka Y; Tahira T; Suzuki T; Onda M; Sugimura T; Nagao M
Oncogene; 1990 Sep; 5(9):1291-6. PubMed ID: 2216455
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma.
Svensson T; Rydén M; Schilling FH; Dominici C; Sehgal R; Ibáñez CF; Kogner P
Eur J Cancer; 1997 Oct; 33(12):2058-63. PubMed ID: 9580079
[TBL] [Abstract][Full Text] [Related]
8. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor.
Lavenius E; Gestblom C; Johansson I; Nånberg E; Påhlman S
Cell Growth Differ; 1995 Jun; 6(6):727-36. PubMed ID: 7669728
[TBL] [Abstract][Full Text] [Related]
9. trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study.
Tanaka T; Hiyama E; Sugimoto T; Sawada T; Tanabe M; Ida N
Cancer; 1995 Sep; 76(6):1086-95. PubMed ID: 8625212
[TBL] [Abstract][Full Text] [Related]
10. Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients.
Itoh F; Ishizaka Y; Tahira T; Yamamoto M; Miya A; Imai K; Yachi A; Takai S; Sugimura T; Nagao M
Oncogene; 1992 Jun; 7(6):1201-6. PubMed ID: 1350670
[TBL] [Abstract][Full Text] [Related]
11. The trk family of oncogenes and neurotrophin receptors.
Lamballe F; Klein R; Barbacid M
Princess Takamatsu Symp; 1991; 22():153-70. PubMed ID: 1844238
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.
Azar CG; Scavarda NJ; Nakagawara A; Brodeur GM
Prog Clin Biol Res; 1994; 385():169-75. PubMed ID: 7972209
[TBL] [Abstract][Full Text] [Related]
13. Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis.
Rydén M; Sehgal R; Dominici C; Schilling FH; Ibáñez CF; Kogner P
Br J Cancer; 1996 Sep; 74(5):773-9. PubMed ID: 8795581
[TBL] [Abstract][Full Text] [Related]
14. The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor.
Meakin SO; Suter U; Drinkwater CC; Welcher AA; Shooter EM
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2374-8. PubMed ID: 1312719
[TBL] [Abstract][Full Text] [Related]
15. Prognostic discrimination among neuroblastomas according to Ha-ras/trk A gene expression: a comparison of the profiles of neuroblastomas detected clinically and those detected through mass screening.
Tanaka T; Sugimoto T; Sawada T
Cancer; 1998 Oct; 83(8):1626-33. PubMed ID: 9781958
[TBL] [Abstract][Full Text] [Related]
16. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
[TBL] [Abstract][Full Text] [Related]
17. Expression of ret proto-oncogene in human neuroblastomas.
Nagao M; Ishizaka Y; Nakagawara A; Kohno K; Kuwano M; Tahira T; Itoh F; Ikeda I; Sugimura T
Jpn J Cancer Res; 1990 Apr; 81(4):309-12. PubMed ID: 1694838
[TBL] [Abstract][Full Text] [Related]
18. Sequence and characterisation of the RET proto-oncogene 5' flanking region: analysis of retinoic acid responsiveness at the transcriptional level.
Patrone G; Puliti A; Bocciardi R; Ravazzolo R; Romeo G
FEBS Lett; 1997 Dec; 419(1):76-82. PubMed ID: 9426223
[TBL] [Abstract][Full Text] [Related]
19. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.
Takahashi M; Buma Y; Iwamoto T; Inaguma Y; Ikeda H; Hiai H
Oncogene; 1988 Nov; 3(5):571-8. PubMed ID: 3078962
[TBL] [Abstract][Full Text] [Related]
20. Activation of trk-A but not trk-B signal transduction pathway inhibits growth of neuroblastoma cells.
Lucarelli E; Kaplan D; Thiele CJ
Eur J Cancer; 1997 Oct; 33(12):2068-70. PubMed ID: 9516854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
